Globus Medical
GMED
500 hedge funds and large institutions have $9.01B invested in Globus Medical in 2024 Q4 according to their latest regulatory filings, with 104 funds opening new positions, 169 increasing their positions, 153 reducing their positions, and 43 closing their positions.
142% more first-time investments, than exits
New positions opened: 104 | Existing positions closed: 43
110% more call options, than puts
Call options by funds: $24.5M | Put options by funds: $11.7M
16% more capital invested
Capital invested by funds: $7.74B → $9.01B (+$1.27B)
11% more funds holding
Funds holding: 449 → 500 (+51)
10% more repeat investments, than reductions
Existing positions increased: 169 | Existing positions reduced: 153
6% more funds holding in top 10
Funds holding in top 10: 18 → 19 (+1)
0.11% more ownership
Funds ownership: 95.67% → 95.78% (+0.11%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$82.5M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$77.7M |
| 3 |
RI
RTW Investments
New York
|
+$76.7M |
| 4 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
+$66.6M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$60.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$95.8M |
| 2 |
MAP
Madison Avenue Partners
New York
|
-$81.3M |
| 3 |
Bank of New York Mellon
New York
|
-$79.5M |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$73M |
| 5 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$54.9M |
GMED Hedge Fund Activity: Q4 2024 in Review
500 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q4 2024, worth a combined $9.01B — up 16% from $7.74B a quarter earlier.
Buyers outnumbered sellers: 104 funds opened new GMED positions and 43 closed out — a net gain of 61 holders — while 169 added to existing stakes and 153 trimmed.
The largest buyer was Millennium Management, adding an estimated $82.5M. The largest seller was Magnetar Financial, cutting an estimated $95.8M.
- 500 institutional investors held Globus Medical (GMED) as of Q4 2024, up from 449 in Q3 2024.
- Funds reported $9.01B of Globus Medical stock for Q4 2024, up 16% quarter-over-quarter.
- 104 funds opened new Globus Medical positions in Q4 2024 and 43 closed out, a net change of +61 holders.
- The largest Globus Medical buyer in Q4 2024 was Millennium Management, an estimated $82.5M added.
- The largest Globus Medical seller in Q4 2024 was Magnetar Financial, an estimated $95.8M sold.
Based on aggregated 13F filings for Q4 2024.